109 related articles for article (PubMed ID: 10704105)
21. Phosphorylation of 3'-azidothymidine in maternal and fetal peripheral blood mononuclear cells during gestation and at term.
Agbaria R; Manor E; Barak J; Balzarini J
J Acquir Immune Defic Syndr; 2003 Apr; 32(5):477-81. PubMed ID: 12679697
[TBL] [Abstract][Full Text] [Related]
22. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
Mascolini M
AIDS Treat News; 1996 Dec; (No 260):3-5. PubMed ID: 11364022
[TBL] [Abstract][Full Text] [Related]
23. CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.
Vermeire K; Princen K; Hatse S; De Clercq E; Dey K; Bell TW; Schols D
AIDS; 2004 Nov; 18(16):2115-25. PubMed ID: 15577644
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP.
Janneh O; Owen A; Chandler B; Hartkoorn RC; Hart CA; Bray PG; Ward SA; Back DJ; Khoo SH
AIDS; 2005 Dec; 19(18):2097-102. PubMed ID: 16284458
[TBL] [Abstract][Full Text] [Related]
25. In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.
Mengoni F; Lichtner M; Battinelli L; Marzi M; Mastroianni CM; Vullo V; Mazzanti G
Planta Med; 2002 Feb; 68(2):111-4. PubMed ID: 11859458
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed.
Bellman PC
AIDS; 1998 Jul; 12(11):1333-40. PubMed ID: 9708413
[TBL] [Abstract][Full Text] [Related]
27. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
Chang S; Griesgraber GW; Southern PJ; Wagner CR
J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
[TBL] [Abstract][Full Text] [Related]
28. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339
[TBL] [Abstract][Full Text] [Related]
29. Delavirdine combination and viral load.
Anderson S
AIDS Treat News; 1997 Oct; (No 281):6. PubMed ID: 11364793
[TBL] [Abstract][Full Text] [Related]
30. The entry of antiviral and antiretroviral drugs into the central nervous system.
Groothuis DR; Levy RM
J Neurovirol; 1997 Dec; 3(6):387-400. PubMed ID: 9475111
[TBL] [Abstract][Full Text] [Related]
31. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
[TBL] [Abstract][Full Text] [Related]
32. In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophages.
Been-Tiktak AM; de Haas CJ; de Graaf L; Boucher CA; Verhoef J; Borleffs JC; Nottet HS; Schuurman R
J Antimicrob Chemother; 1997 Dec; 40(6):847-53. PubMed ID: 9462437
[TBL] [Abstract][Full Text] [Related]
33. Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients.
Nagano D; Araki T; Yanagisawa K; Ogawa Y; Gohda F; Uchiumi H; Handa H; Nakamura T; Yamamoto K
Eur J Clin Pharmacol; 2018 Aug; 74(8):1055-1060. PubMed ID: 29721582
[TBL] [Abstract][Full Text] [Related]
34. Effect of nucleoside and nucleotide analog reverse transcriptase inhibitors on cell-mediated immune functions.
Enomoto L; Anderson PL; Li S; Edelstein CL; Weinberg A
AIDS Res Hum Retroviruses; 2011 Jan; 27(1):47-55. PubMed ID: 20929390
[TBL] [Abstract][Full Text] [Related]
35. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.
Bacheler L; Jeffrey S; Hanna G; D'Aquila R; Wallace L; Logue K; Cordova B; Hertogs K; Larder B; Buckery R; Baker D; Gallagher K; Scarnati H; Tritch R; Rizzo C
J Virol; 2001 Jun; 75(11):4999-5008. PubMed ID: 11333879
[TBL] [Abstract][Full Text] [Related]
36. Short-term effects of the 21-aminosteroid lazaroid tirilazad mesylate (PNU-74006F) and the pyrrolopyrimidine lazaroid PNU-101033E on energy metabolism of human peripheral blood mononuclear cells.
Schmid D; Burmester GR; Tripmacher R; Fici G; von Voigtlander P; Buttgereit F
Biosci Rep; 2001 Feb; 21(1):101-10. PubMed ID: 11508689
[TBL] [Abstract][Full Text] [Related]
37. Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells.
Törnevik Y; Jacobsson B; Britton S; Eriksson S
AIDS Res Hum Retroviruses; 1991 Sep; 7(9):751-9. PubMed ID: 1742082
[TBL] [Abstract][Full Text] [Related]
38. Ribosomal inhibitory proteins from plants inhibit HIV-1 replication in acutely infected peripheral blood mononuclear cells.
Olson MC; Ramakrishnan S; Anand R
AIDS Res Hum Retroviruses; 1991 Dec; 7(12):1025-30. PubMed ID: 1725958
[TBL] [Abstract][Full Text] [Related]
39. Quantitation of intracellular triphosphate metabolites of antiretroviral agents in peripheral blood mononuclear cells (PBMCs) and corresponding cell count determinations: review of current methods and challenges.
Xiao D; Ling KHJ; Custodio J; Majeed SR; Tarnowski T
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):781-802. PubMed ID: 30010446
[TBL] [Abstract][Full Text] [Related]
40. Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs.
Meng Q; Olivero OA; Fasco MJ; Bellisario R; Kaminsky L; Pass KA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Bigbee WL; O'Neill JP; Walker DM; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):307-21. PubMed ID: 17358024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
